Athletic training

NanoVibronix Ships First Order of PainShield Plus

Monday, July 26, 2021 - 3:47pm

NanoVibronix, Inc ., (NASDAQ: NAOV), a medical device company that produces the UroShield and PainShield Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it has fulfilled the first order of its next generation pain management device, PainShield Plus, and expects to recognize revenue for the sale in the third quarter of 2021.

Key Points: 
  • NanoVibronix, Inc ., (NASDAQ: NAOV), a medical device company that produces the UroShield and PainShield Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it has fulfilled the first order of its next generation pain management device, PainShield Plus, and expects to recognize revenue for the sale in the third quarter of 2021.
  • PainShield Plus covers two times the surface area for pain therapy and is sold at a higher gross margin compared to the original PainShield MD.
  • This first shipment represents a significant milestone for our patent pending PainShield Plus, stated Brian Murphy, Chief Executive Officer of NanoVibronix, Inc. We launched the device late in 2020 to overwhelmingly positive response from orthopedic and neurological patients and healthcare providers.
  • PainShield Plus, like the original PainShield, utilizes ultrasound therapy for the treatment of pain and various soft tissue injuries either directly over joints or orthopedic hardware and without the need for messy ultrasound gels.

Local Miami High School Chosen to Receive Athletic Training Donation from Medco in Partnership With Cramer and PFATS

Thursday, July 22, 2021 - 6:44pm

MIAMI, July 22, 2021 /PRNewswire/ --Miami Norland Senior High School has been chosen as a recipient of the 2021 High School Initiative, an athletic training donation program sponsored by a partnership between Medco Sports Medicine (Medco), the leading supplier of athletic training and sports medicine products; Cramer Sports Medicine (Cramer), a leading manufacturer of sports medicine products; and the Professional Football Athletic Trainers Society (PFATS), representing the athletic trainers of the National Football League (NFL).

Key Points: 
  • MIAMI, July 22, 2021 /PRNewswire/ --Miami Norland Senior High School has been chosen as a recipient of the 2021 High School Initiative, an athletic training donation program sponsored by a partnership between Medco Sports Medicine (Medco), the leading supplier of athletic training and sports medicine products; Cramer Sports Medicine (Cramer), a leading manufacturer of sports medicine products; and the Professional Football Athletic Trainers Society (PFATS), representing the athletic trainers of the National Football League (NFL).
  • The initiative seeks to ensure that high school athletic trainers receive essential supplies and equipment necessary to provide athletic health care to student athletes.
  • Miami Norland is one of four high schools across the country to receive the donation of $2,000 in athletic training supplies and equipment, selected as the recipient high school of the Miami Dolphins NFL community.
  • Medco, PFATS, Cramer, and members of the Miami Dolphins' athletic training staff presented the donation to Pete Martz, Athletic Trainer at Miami Norland Senior High School, accompanied by
    Latoya Williams, Athletic Director; and David Ladd, Principal.

Marc Pro Named Official Recovery Technology Partner of Perfect Game

Wednesday, July 14, 2021 - 4:00pm

CEDAR RAPIDS, Iowa, July 14, 2021 /PRNewswire/ -- Perfect Game , the world's largest youth baseball and softball platform and scouting service, today announced it has entered into a multiyear agreement making Huntington, CA based Marc Pro its official recovery technology partner.

Key Points: 
  • CEDAR RAPIDS, Iowa, July 14, 2021 /PRNewswire/ -- Perfect Game , the world's largest youth baseball and softball platform and scouting service, today announced it has entered into a multiyear agreement making Huntington, CA based Marc Pro its official recovery technology partner.
  • Marc Pro is a cutting-edge, electronic muscle stimulation (EMS) tool that delivers effective muscle recovery through patented technology that creates non-fatiguing muscle activation scientifically proven to enhance each stage of the muscle recovery process.
  • "We're very happy to welcome Marc Pro to the Perfect Game family.
  • "The Marc Pro team is so excited to partner with Perfect Game in helping young athletes get to the next level," said Marc Pro CEO, Ryan Heaney.

Wearable Ultrasounds Poised to Revolutionize Healing and Pain Management Healthcare Market

Tuesday, June 29, 2021 - 10:10pm

The result, Sustained Acoustic Medicine (sam), was found to be capable of altering the trajectory of soft tissue cells to stimulate remodeling and healing.

Key Points: 
  • The result, Sustained Acoustic Medicine (sam), was found to be capable of altering the trajectory of soft tissue cells to stimulate remodeling and healing.
  • Initially commercialized for the veterinary market in 2010, the company's productULTROZwas used to heal soft tissue injuries in dogs and horses.
  • By 2014, ZetrOZ had pivoted to exclusively serve the human market, building on an existing low-intensity pulsed ultrasound medical technology called Exogen.
  • Their flagship product, sam, is an in-home, ultrasound treatment that reduces the need for pain medication and surgery.

ImPACT Applications Launches Exclusive Partnership with ConnecME Education to Bring Concussion Testing to the Middle East and North Africa (MENA) Regions

Monday, June 7, 2021 - 3:00pm

SAN DIEGO, June 7, 2021 /PRNewswire-PRWeb/ -- ImPACT Applications, Inc., the leading provider of concussion assessment tools, and ConnecME Education, an international educational company that offers tailored assessment solutions, have partnered to bring ImPACT baseline and post-injury testing to the Middle East and North Africa regions.

Key Points: 
  • SAN DIEGO, June 7, 2021 /PRNewswire-PRWeb/ -- ImPACT Applications, Inc., the leading provider of concussion assessment tools, and ConnecME Education, an international educational company that offers tailored assessment solutions, have partnered to bring ImPACT baseline and post-injury testing to the Middle East and North Africa regions.
  • "We are proud to partner with ConnecME to help deliver best-in-class concussion tools to their customers in the Middle East and Africa.
  • This is yet another step towards raising concussion awareness, increasing access to quality concussion care, and improving concussion outcomes worldwide.
  • With ImPACT Applications as an exclusive partner, ConnecME is making pathways in bringing these services to multiple sectors across the region.

Alpha Cognition to Host Virtual R&D Day on June 22, 2021

Thursday, June 3, 2021 - 1:00pm

Alpha Cognition Inc. (TSX-V: ACOG) (Alpha Cognition or the Company), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, is pleased to announce that it will host its first annual Virtual R&D Day for analysts and investors on Tuesday, June 22, 2021, from 1:00PM to 3:00PM EDT.

Key Points: 
  • Alpha Cognition Inc. (TSX-V: ACOG) (Alpha Cognition or the Company), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, is pleased to announce that it will host its first annual Virtual R&D Day for analysts and investors on Tuesday, June 22, 2021, from 1:00PM to 3:00PM EDT.
  • He is also the co-chair of the Florida High School Athletic Concussion committee and has been involved in drafting concussion and TBI guidelines.
  • After the formal presentation, investors will have an opportunity to ask relevant questions through an interactive Q&A portal.
  • This data involves a number of assumptions and limitations, and you are cautioned not to give undue weight to such estimates.

Odyssey Group International Announces Successful Completion of Their Novel Nano-Particle Drug Formulation for Treating Concussion

Wednesday, June 2, 2021 - 12:30pm

Irvine, CA, June 02, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB: ODYY ) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique, life-saving medical products, today announced the completion of their novel nano-particle drug formulation.

Key Points: 
  • Irvine, CA, June 02, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB: ODYY ) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique, life-saving medical products, today announced the completion of their novel nano-particle drug formulation.
  • The drug formulation was designed to enhance brain distribution of its lead drug candidate, PRV-002, to treat concussion (mild traumatic brain injury).
  • The combined nature of our new formulation and novel nasal device will maximize the exposure of the traumatized brain to our drug following concussion and give the best chance for effective treatment, commented Jacob VanLandingham, Executive VP of Drug Development of Odyssey Group International.
  • The novel nanoparticle drug formulation will improve safety by reducing exposure to areas of the body other than the intended treatment area, the brain,
    The drug, a novel neurosteroid being developed to treat concussion, has been formulated into a nano-particle powder.

ZetrOZ Provides Veterans With Proven Non-Invasive, Non-Narcotic Pain Relief and Soft Tissue Healing

Tuesday, June 1, 2021 - 5:52pm

Nowhe relies on ZetrOZ Systems' sustained acoustic medicine (SAM) device for effective and non-narcotic pain relief.

Key Points: 
  • Nowhe relies on ZetrOZ Systems' sustained acoustic medicine (SAM) device for effective and non-narcotic pain relief.
  • SAM uses continuous ultrasound therapy applied to deep tissue to accelerate natural healing at the molecular level.
  • The continuous therapy inhibits inflammation and increases the rate of tissue regeneration, angiogenesis, and nutrient exchange in deep musculoskeletal tissue.
  • ZetrOZ Systems produced UltrOZ, samSport and samPro 2.0 to provide safe and effective treatment options for prevalent conditions such as arthritis.

Oculogica Receives Department of Defense Grant to Develop Wearable Concussion Diagnostic with Pre-eminent Partners

Tuesday, May 18, 2021 - 2:57pm

These awards are designed to fund efforts to provide significant leaps forward in medical technology.

Key Points: 
  • These awards are designed to fund efforts to provide significant leaps forward in medical technology.
  • The earlier we can detect a concussion, the greater the likelihood of a good outcome.
  • We have been studying eye-tracking as part of a multi-modal assessment of concussion for several years in the clinic.
  • The company has developed the EyeBOX, the first and only FDA cleared baseline-free aid in diagnosis of concussion to help physicians objectively categorize concussion.

BrainScope Launches Next-Gen Medical Device: First and only FDA-cleared system for true point-of-care assessment of both concussion and brain bleeds now includes Concussion Index

Tuesday, March 23, 2021 - 12:46pm

The Concussion Index adds to the suite of FDA cleared algorithms already available on the BrainScope device and in clinical use today to rapidly triage suspected mild traumatic brain injuries, from brain bleeds to concussion.

Key Points: 
  • The Concussion Index adds to the suite of FDA cleared algorithms already available on the BrainScope device and in clinical use today to rapidly triage suspected mild traumatic brain injuries, from brain bleeds to concussion.
  • The results are immediately available and enable doctors to get rapid, objective insights about the likelihood of brain bleeds and concussions.
  • "With the addition of the AI-derived Concussion Index, BrainScope adds important new baselining and follow-up capabilities to aid physicians in concussion management," said Susan Hertzberg, CEO of BrainScope.
  • BrainScope is a medical neurotechnology company that is improving brain health by providing objective, diagnostic insights that enable better patient care.